Introduction
Anyone searching for a straight answer on selank dosage usually runs into the same problem: forum threads that contradict each other, vendor pages that recycle the same three sentences, and no single source that lays out what published research actually documents. That gap creates real friction for researchers trying to design a defensible protocol.
Featured Product
This guide pulls together the intranasal and subcutaneous selank dosage ranges referenced in the literature, walks through reconstitution step by step, and compares selank nasal spray against injectable formats. It also covers the selank peptide's mechanism of action, the side effects reported in research settings, and how selank and semax are combined in stress-response study designs.
Every figure in this article is framed for laboratory research use only (RUO) — this is not medical dosing guidance, and selank is not approved by the FDA for human consumption. By the end, you'll have a reference-ready dosage chart, a reconstitution walkthrough, and a supplier-vetting checklist you can apply to your own study design.
What Is Selank Peptide?
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at Russia's Institute of Molecular Genetics as a structural analogue of tuftsin, a naturally occurring immunomodulatory peptide. Researchers modified the tuftsin backbone with a Pro-Gly-Pro sequence, which extends its resistance to enzymatic degradation and gives it a longer functional half-life than the parent compound.
In research literature, selank is most often discussed alongside GABA-B receptor modulation and anxiolytic peptide research models, which is why it shows up so frequently in stress-response and neuropeptide pharmacokinetics studies. It's classified as a nootropic peptide in much of that literature, distinct from stimulant or sedative mechanisms.
Selank vs. Semax at a Glance
Selank is frequently studied alongside semax, its better-known laboratory sibling. Both share the Pro-Gly-Pro stabilization motif, but they come from different parent structures and different receptor-research pathways.
Attribute | Selank | Semax |
|---|---|---|
Parent Compound | Tuftsin analogue | ACTH(4-10) analogue |
Primary Research Focus | GABA-B / anxiolytic models | BDNF / cognitive research models |
Common Delivery Route | Intranasal, subcutaneous | Intranasal |
Structural Motif | Pro-Gly-Pro stabilized | Pro-Gly-Pro stabilized |
For a full structural and research-application comparison, see our Semax vs. Selank guide.
Selank Dosage in Published Research
A typical selank dosage referenced across published research protocols falls in a defined range depending on the administration route and the study's design. There is no single standardized selank dosing protocol across the literature — researchers calibrate intranasal and subcutaneous amounts differently, and dosing frequency varies by study duration.
Typical Intranasal Selank Dosage Ranges
Intranasal administration is the delivery route most frequently referenced in selank research, largely because it bypasses first-pass metabolism and allows for straightforward dose-splitting across a research day.
- Research protocols commonly reference nasal-spray formulations delivering a fixed microgram amount per spray, calibrated to the total reconstituted concentration.
- Multiple daily administrations (typically two to three) are more common in the literature than a single daily dose, reflecting selank's relatively short functional window.
- Dosing frequency and total daily amount are study-design variables — researchers should define both before beginning data collection, not adjust them mid-protocol.
Typical Subcutaneous Selank Dosage Ranges
Subcutaneous injection dosage protocols reference smaller reconstituted volumes than nasal administration, since the route delivers a more direct systemic uptake. Research-grade insulin syringes are the standard measurement tool referenced for this route.
- Subcutaneous selank dosage protocols are typically calculated in micrograms per kilogram of research-subject body weight, then converted to a syringe-unit volume based on the reconstitution concentration.
- Injection-site rotation and sterile technique are standard practice across the subcutaneous administration literature.
Selank Dosage Chart
The table below summarizes commonly referenced format, concentration range, and delivery route combinations. Use it as a starting reference point for protocol design, not as a fixed prescription.
Format | Typical Concentration Range | Delivery Route | Notes |
|---|---|---|---|
Lyophilized vial (5mg) | 5mg per vial | Reconstitute before use | Common starting vial size |
Lyophilized vial (10mg) | 10mg per vial | Reconstitute before use | Higher-concentration research batches |
Nasal spray (reconstituted) | Study-defined mcg/spray | Intranasal | Most-referenced route in literature |
Injectable (reconstituted) | Study-defined mcg/kg | Subcutaneous | Requires research-grade syringe |
Key Takeaway: Selank dosage in research literature is route-dependent — intranasal protocols reference microgram-per-spray amounts, while subcutaneous protocols reference microgram-per-kilogram calculations converted to syringe units.
How to Reconstitute Selank Peptide for Research
Reconstitution accuracy determines whether a selank dosing protocol is reproducible. The two most common questions researchers ask are how do I reconstitute selank and how much bacteriostatic water do I use — both come down to the vial's labeled mg amount and the target concentration for your protocol.
Bacteriostatic Water Dilution Ratios
Bacteriostatic water is the standard diluent referenced across peptide reconstitution literature because its preservative content extends the reconstituted solution's usable window compared to plain sterile water.
- A 5mg selank vial reconstituted with 2mL of bacteriostatic water yields a 2.5mg/mL concentration.
- A 10mg selank vial reconstituted with 2mL of bacteriostatic water yields a 5mg/mL concentration.
- Researchers can adjust the water volume up or down to hit a specific target concentration for their protocol's syringe-unit math.
Step-by-Step Reconstitution
- Bring the lyophilized selank vial and bacteriostatic water to room temperature before mixing.
- Wipe both vial stoppers with an alcohol swab.
- Draw the calculated volume of bacteriostatic water into a sterile syringe.
- Insert the needle at an angle and inject the water slowly down the interior wall of the vial — never directly onto the lyophilized powder.
- Gently swirl the vial until the powder fully dissolves. Do not shake; agitation can degrade the peptide structure.
- Label the vial with the reconstitution date and concentration, then store according to the storage guidance below.
Selank Administration Routes: Nasal Spray vs. Injectable
Selank nasal spray and injectable subcutaneous formats are the two delivery routes referenced most often in the research literature, and each carries different practical trade-offs for a lab setting.
Factor | Nasal Spray | Subcutaneous Injectable |
|---|---|---|
Ease of Administration | Straightforward, no needle handling | Requires sterile injection technique |
Onset Referenced in Literature | Faster mucosal absorption | Direct systemic delivery |
Dosing Precision | Per-spray calibration | Per-unit syringe calculation |
Common Research Setting | Behavioral / stress-response studies | Pharmacokinetic studies |
Selank Mechanism of Action
Selank's research mechanism centers on GABA-B receptor modulation, inherited in part from its tuftsin lineage and modified by the added Pro-Gly-Pro sequence. This structural addition is what gives selank its extended resistance to enzymatic breakdown relative to unmodified tuftsin, which is the basis for its longer referenced functional window in stress-response research models.
Because selank sits in the same structural family as semax — both peptides use the Pro-Gly-Pro stabilization motif — researchers frequently study them in parallel, comparing GABA-B pathway research against semax's BDNF-linked cognitive research applications.
Selank Side Effects & Safety Considerations Reported in Research
Selank side effects reported in the peptide research literature are generally described as mild and route-dependent. This section summarizes what's documented — it is not a substitute for a full safety review specific to your protocol.
- Mild nasal irritation is the most frequently reported effect associated with intranasal administration.
- Injection-site reactions (redness, mild swelling) are occasionally reported with subcutaneous administration, consistent with peptide-injection literature broadly.
- Fatigue and transient drowsiness appear in some research reports, though findings are not consistent across all studies.
- Selank withdrawal is not well characterized in the published literature, and researchers should treat any discontinuation-related observations as a data point for further study rather than an established finding.
This section reflects RUO literature summaries only. Selank is not FDA-approved and is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Selank and Semax Combined Research Protocols
Selank and semax are commonly referenced together in combined-protocol research designs, since both peptides share the Pro-Gly-Pro stabilization structure but act on different research pathways — selank on GABA-B/anxiolytic models, semax on BDNF/cognitive models.
Researchers investigating a selank and semax stack typically administer both via nasal spray, staggering timing rather than combining them in a single reconstituted solution, to keep each compound's dosing variable independently trackable.
Selank Storage & Shelf Life
Storage protocol depends on whether the selank is still lyophilized or already reconstituted.
- Unreconstituted, lyophilized selank should be stored in a freezer, protected from light, until ready for use.
- Reconstituted selank should be refrigerated (not frozen) and used within the timeframe established by your lab's stability protocol.
- Repeated freeze-thaw cycles and exposure to light are the two most common causes of premature peptide degradation referenced in storage literature.
For a full breakdown of temperature ranges, degradation causes, and cold-chain handling, see our Research Peptide Storage & Handling guide.
Choosing a Research-Grade Selank Peptide Supplier
Dosage accuracy only matters if the underlying peptide is what the label claims. Before finalizing any selank dosing protocol, verify the supplier's documentation.
- Request a current third-party Certificate of Analysis (COA) confirming purity via HPLC testing.
- Confirm the vial's labeled mg amount matches the COA's tested concentration.
- Check that the supplier ships cold-chain-verified, RUO-labeled product with lot-level traceability.
- Avoid suppliers that cannot produce a lot-specific COA on request — this is the single most common red flag in peptide-sourcing research.
For a deeper walkthrough of purity verification standards, see How to Choose High-Purity Research Peptides and our ≥99% Purity Verification hub.
Common Selank Dosing Mistakes to Avoid
- Reconstituting with plain sterile water instead of bacteriostatic water, shortening the usable window.
- Shaking rather than gently swirling the vial, which can damage the peptide's structure.
- Skipping a dated reconstitution label, making it impossible to track shelf-life accurately.
- Changing dosing frequency mid-protocol without documenting the change, which compromises study reproducibility.
- Sourcing from a supplier that can't provide a lot-specific COA.
Key Takeaways
- Selank is a tuftsin-analogue heptapeptide studied primarily for GABA-B receptor modulation in anxiolytic and stress-response research models.
- Selank dosage in the literature is route-dependent: intranasal protocols reference microgram-per-spray amounts; subcutaneous protocols reference microgram-per-kilogram calculations.
- Reconstitution accuracy — correct bacteriostatic water ratio, gentle mixing, dated labeling — is what makes a selank dosing protocol reproducible.
- Selank nasal spray and subcutaneous injectable formats each carry different practical trade-offs for administration precision and research setting.
- Selank and semax are frequently studied in combined protocols due to their shared Pro-Gly-Pro structural motif.
- A verified third-party COA is non-negotiable before finalizing any selank dosage protocol.
- This content is RUO-framed throughout: selank is not FDA-approved and is not intended for human consumption.
Frequently Asked Questions
What is Selank peptide?
Selank is a synthetic heptapeptide developed as a structural analogue of tuftsin, studied primarily in GABA-B receptor and anxiolytic peptide research.
What is Selank used for in laboratory research?
Research applications center on stress-response, anxiolytic, and neuropeptide pharmacokinetics models, framed strictly as research use only.
What is a typical Selank dosage referenced in published research?
Dosage is route-dependent — intranasal protocols reference microgram-per-spray amounts, while subcutaneous protocols reference microgram-per-kilogram calculations.
How is Selank typically dosed intranasally in research protocols?
Nasal-spray protocols commonly reference two to three administrations per research day, calibrated to the reconstituted concentration.
How is Selank typically dosed via subcutaneous injection?
Subcutaneous protocols calculate a microgram-per-kilogram amount, then convert it to a syringe-unit volume based on the reconstitution concentration.
How do I reconstitute Selank peptide?
Selank is reconstituted by slowly injecting bacteriostatic water down the interior vial wall and gently swirling — never shaking — until the powder fully dissolves.
How much bacteriostatic water is used to reconstitute Selank?
A common reference point is 2mL of bacteriostatic water per 5mg or 10mg vial, adjusted to hit the target concentration for a given protocol.
Is Selank the same peptide as Semax?
No. Selank is a tuftsin analogue studied in GABA-B/anxiolytic models, while semax is an ACTH(4-10) analogue studied in BDNF/cognitive models. Both share a Pro-Gly-Pro stabilization motif.
Can Selank and Semax be combined in research protocols?
Yes — researchers commonly reference combined selank-and-semax protocols, typically administered separately by nasal spray with staggered timing rather than mixed in one solution.
What side effects are reported for Selank in research literature?
Reported effects are generally mild and route-dependent: nasal irritation with intranasal use, and occasional injection-site reactions with subcutaneous use.
Is Selank FDA approved?
No. Selank is not FDA-approved and is sold strictly for research use only, not for human consumption.
Does Selank need to be refrigerated?
Reconstituted selank should be refrigerated. Unreconstituted, lyophilized selank is stored frozen and protected from light.
Where can Selank peptide purity be verified?
Purity is verified through a supplier's third-party Certificate of Analysis (COA), which reports HPLC-tested concentration against the vial's labeled amount.
What is the mechanism of action of Selank?
Selank research centers on GABA-B receptor modulation, supported by its Pro-Gly-Pro-extended resistance to enzymatic degradation.
What research exists on Selank and stress-response modulation?
Selank is studied in stress-response and anxiolytic peptide research models building on its tuftsin lineage and GABA-B pathway involvement; researchers should consult primary literature for study-specific findings.
